SLC7A11 is highly expressed in various malignant tumors, and tumor cells can maintain high levels of GSH by upregulating SLC7A11 expression to counteract oxidative stress caused by increased metabolic rate, a process that is positively correlated with cancer progression because of its antioxidant function [35]. Here, SLC7A11 is linked to cancer.